Patent ID: 6458923
Filing Date: 2002-10-01
Classification: A61K,C07K,Y10S

Abstract:
A peptide having the formula:Nâ€”Aâ€”Bâ€”Câ€”Dâ€”Eâ€”Fâ€”Gâ€”Hâ€”Iâ€”Jâ€”Cn whereinN is hydrogen; A is selected from the group consisting of L-Arg, D-Arg, Lys-Lys, L-Lys, and D-Lys; B is selected from the group consisting of L-Arg, D-Arg, and Lys; C and D are independently selected from the group consisting of Pro, dehydropro, and hydroxypro; E is Gly; F is selected from the group consisting of Phe and Thi; G is a direct bond or is selected from the group consisting of Ser and Thr; H is a compound of the D-configuration having the formula selected from the group consisting of: I is selected from the group consisting of Oic, Aoc and Tic; J is selected from the group consisting of Arg and Lys; Cn is a hydroxyl group; and pharmaceutically acceptable salts thereof.